吉林中医药2017，Vol.37Issue(5)：520-524,5.DOI:10.13463/j.cnki.jlzyy.2017.05.026
三九三七粉配方颗粒的优势分析
Analysis of the advantages of SanJiu Notoginseng Radix et Rhizoma formula granules
摘要
Abstract
Objective By observing traits and experimental analysis to compare different the advantages of SanJiu Notoginseng Radix et Rhizoma formula granules, revealing the advantages of SanJiu Notoginseng Radix et Rhizoma formula granules. Methods By comparing the contents of total saponins and prices from 10 different sources of Panax notoginseng, to determine the SanJiu Notoginseng Radix et Rhizoma formula granules medicinal materials. Choose 13 different batches of Notoginseng powder formula particles from five different manufacturers by observing and analyzing their characteristics, blots of TLC analysis and content toprove that the SanJiu Notoginseng Radix et Rhizoma formula granules are the best. Results In order to produce notoginseng powder formula particles, we use mass production slices for raw material, which are of great quality and low cost. By observing, the character of SanJiu Notoginseng Radix et Rhizoma formula granules better than the others.The Results of TLC analysis shows that the particles of every manufacturer are standard requested. The results of determination shows the equivalent of SanJiu Notoginseng Radix et Rhizoma formula granules is 1.5 meaning that 1gram medical slice contains 126.4 to 115.2 milligram, which is far higher than the other competitors. Conclusion The method used in the research is simple and convenient. Comparing with others, SanJiu Notoginseng Radix et Rhizoma formula granules show the advantages of greater quality, lower cost and better characters, higher total saponins, which is appropriate for the tender samples exhibition.关键词
三七粉配方颗粒/优势/性状/薄层分析/含量测定Key words
SanJiu Notoginseng Radix et Rhizoma formula granules/advantages/characters/TLC analysis/determination分类
医药卫生引用本文复制引用
罗桂贤,刘玥欣,叶豆丹..三九三七粉配方颗粒的优势分析[J].吉林中医药,2017,37(5):520-524,5.基金项目
全国中药特色技术传承人才培训项目 （）
国家中医药优势特色教育培训基地(中药)项目 （中药）
吉林省中医药管理局中医药政策与发展研究项目(zcyj-2016-13). （zcyj-2016-13）
